Impel Pharmaceuticals Inc. products

Impel Pharmaceuticals has developed a proprietary drug delivery technology system that targets the vascular-rich upper nasal space,¹ with multiple clinical trials suggesting rapid absorption and consistent drug bioavailability with ease of use in mind for a patient, provider or caregiver. Impel Pharmaceuticals proprietary Precision Olfactory Delivery (POD^®) technology has the potential to lead to injection-like bioavailability, which may improve clinical outcomes non-invasively.